The expeditious advancement of Alzheimer's Disease (AD) is a threat to the global
healthcare system, that is further supplemented by therapeutic failure. The prevalence of this …

Aging is a significant risk factor for Alzheimer's disease (AD), although the precise
mechanism and molecular basis of AD are not yet fully understood. Epigenetic mechanisms …

An important motivation for the construction of biobanks is to discover biomarkers that
identify diseases at early, potentially curable stages. This will require biobanks from large …

Objective With an increasing incidence of Alzheimer's disease (AD) and neurodegenerative
tauopathies, there is an urgent need to develop reliable biomarkers for the diagnosis and …

A compelling need in the field of neurodegenerative diseases is the development and
validation of biomarkers for early identification and differential diagnosis. The availability of …

Background: Individuals with subjective cognitive decline (SCD) are hypothesized to be the
earliest along the cognitive continuum between healthy aging and Alzheimer's disease (AD) …

Alzheimer's disease (AD) is a slowly progressing disease for which there is no known
therapeutic cure at present. Ongoing research around the world is actively engaged in the …

In the elderly, a debilitating condition known as dementia, which is a major health concern,
is caused by Alzheimer's disease (AD). Despite promising advances by researchers, there is …

Patients with Alzheimer's disease (AD) develop olfactory and gustatory disorders. However,
the order of failure and relevance of the pathophysiology are unclear. We compared …

It is increasingly recognized that Alzheimer's disease (AD) exists before dementia is present
and that shifts in amyloid beta occur long before clinical symptoms can be detected. Early …